生物学的サンプルハンドリング市場：タイプ、製品タイプ、最終用途、用途別-2025-2030年世界予測

生物学的サンプルハンドリング市場は、2023年に186億2,000万米ドルと評価され、2024年には198億5,000万米ドルに達すると予測され、CAGR 6.47%で成長し、2030年には288億8,000万米ドルに達すると予測されています。

生物学的サンプルハンドリング市場には、生物学的サンプルの効果的な管理、処理、保存に必要な幅広い活動が含まれます。このプロセスは、診断検査、創薬、バイオバンクで使用されるサンプルの完全性と生存性を維持するために不可欠です。臨床試験、疫学研究、個別化医療における正確で信頼性の高い結果に対する要求の高まりから、堅牢なサンプルハンドリングの実践の必要性が生じています。サンプルハンドリングの用途は幅広く、臨床検査室、病院、研究機関、製薬会社に及んでいます。成長に影響を与える主な要因としては、慢性疾患の増加、バイオテクノロジーの進歩、高品質のサンプル管理を必要とするゲノム研究の拡大などが挙げられます。また、精密医療や個別化医療への関心の高まりも注目され、取り扱い手順の強化が必要とされています。凍結保存や自動保存システムのような自動化や革新的技術には新たな機会が存在し、サンプル管理の効率を大幅に高めることができます。企業は、データの完全性のためのブロックチェーンや予測的サンプル分析のためのAIなどの分野を活用して競争力を高めることができます。しかし、市場開拓の課題には、厳しい規制要件、高度なハンドリング技術に関連する高コスト、新興国地域での限られた認識などがあります。品質管理の問題も市場開拓に大きなリスクをもたらします。技術革新のための最良の分野には、持続可能性の実践の改善、リアルタイムのモニタリングのためのIoTの統合、より良いデータ管理のためのバイオインフォマティクスの強化が含まれます。新しい保存方法の研究や、環境にやさしく費用対効果の高い保存ソリューションの開発も、成長を促進する可能性があります。市場は非常にダイナミックな性質を持っており、技術的な進歩や主要企業間のパートナーシップに焦点を当て、業務の合理化と事業範囲の拡大を図っています。課題を軽減し、新たな機会を効果的に活用するために、企業は継続的なイノベーションと戦略的提携を優先すべきです。

市場力学：急速に進化する生物学的サンプルハンドリング市場の主要市場インサイトを公開

生物学的サンプルハンドリング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 個別化ヘルスケアにおける流体サンプル管理とハンドリングへのニーズの高まり
  • ゲノミクスとプロテオミクスによる需要の高まりとバイオバンキングの増加
  • バイオマーカー分析の急成長と高度なサンプルハンドリングの必要性
• 市場抑制要因
  • 生物学的サンプルハンドリングに関連する厳しい規制
• 市場機会
  • ライフサイエンス研究開発活動への投資の増加
  • サンプルハンドリングにおける技術の進歩と革新
• 市場の課題
  • 操作に伴う複雑さと特定のハンドリング・プロトコルの必要性

ポーターのファイブフォース：生物学的サンプルハンドリング市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：生物学的サンプルハンドリング市場における外部からの影響の把握

外部マクロ環境要因は、生物学的サンプルハンドリング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析生物学的サンプルハンドリング市場における競合情勢の把握

生物学的サンプルハンドリング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス生物学的サンプルハンドリング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、生物学的サンプルハンドリング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨生物学的サンプルハンドリング市場における成功への道筋を描く

生物学的サンプルハンドリング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • パーソナライズされたヘルスケアにおける体液サンプルの管理と取り扱いの必要性の高まり
    • ゲノミクスとプロテオミクスからの需要の高まりとバイオバンキングの実践の増加
    • バイオマーカー分析の急激な増加と高度なサンプル処理の必要性
  • 抑制要因
    • 生物学的サンプルハンドリングに関連する厳格な規制
  • 機会
    • ライフサイエンス研究開発活動への投資の増加
    • サンプル処理における技術的進歩と革新
  • 課題
    • 操作に伴う複雑さと特定の処理プロトコルの必要性
• 市場セグメンテーション分析
  • 製品：輸送中にウイルスサンプルを保存するための採血キットと綿棒の使用が増加
  • 最終用途：積極的な健康管理を推進する病院における生物学的サンプルハンドリングソリューションの採用増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 生物学的サンプルハンドリング市場：タイプ別

• 細胞と遺伝物質
• 唾液サンプル
• 便サンプル
• 尿サンプル

第7章 生物学的サンプルハンドリング市場：製品別

• 採血キット
• 綿棒
  • 鼻腔スワブ
  • 鼻咽頭スワブ
  • 口腔咽頭スワブ
• ウイルス輸送メディア

第8章 生物学的サンプルハンドリング市場：最終用途別

• 診断センター
• ホームケア
• 病院・クリニック

第9章 生物学的サンプルハンドリング市場：用途別

• 診断
• 調査

第10章 南北アメリカの生物学的サンプルハンドリング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の生物学的サンプルハンドリング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの生物学的サンプルハンドリング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • MedLife、ドローンで研究室のサンプルを輸送
  • BioLizardとParean Biotechnologiesが提携を発表
  • MolGenがSynchron Lab Automationを買収
• 戦略分析と提言

企業一覧

• Accelerated Laboratory Logistics
• Alliance Pharma PLC
• Azenta Life Sciences
• BioDock Limited
• BioLife Solutions Inc.
• Clinigen Group
• Cryoniss
• Cryoport Systems, LLC
• Discovery Life Sciences
• Eppendorf SE
• Hamilton Company
• Infiuss Health
• Labtoo
• Marken by United Parcel Service, Inc.
• Mercury Business Services
• MLM Medical Labs
• Oximio
• PrecisionMed, LLC
• ReproCELL Inc.
• SAROUTE Co., Ltd.
• SPT Labtech Ltd.
• Thermo Fisher Scientific Inc.
• Ziath Ltd.

LIST OF FIGURES

• FIGURE 1. BIOLOGICAL SAMPLE HANDLING MARKET RESEARCH PROCESS
• FIGURE 2. BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BIOLOGICAL SAMPLE HANDLING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BIOLOGICAL SAMPLE HANDLING MARKET DYNAMICS
• TABLE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLULAR & GENETIC MATERIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SALIVA SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STOOL SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE SAMPLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD COLLECTION KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY NASAL SWABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY NASOPHARYNGEAL SWABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY OROPHARYNGEAL SWABS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VIRAL TRANSPORT MEDIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 46. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 47. CANADA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 51. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 52. MEXICO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 56. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. UNITED STATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 62. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 63. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 65. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 68. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. AUSTRALIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 73. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 74. CHINA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 78. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 79. INDIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 83. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 84. INDONESIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 88. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. JAPAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 93. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 94. MALAYSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 98. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 99. PHILIPPINES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 103. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 104. SINGAPORE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 108. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 109. SOUTH KOREA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 113. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. TAIWAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 115. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 116. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 118. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 119. THAILAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 123. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 124. VIETNAM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 131. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 134. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 135. DENMARK BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 137. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 139. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 140. EGYPT BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 144. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 145. FINLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 147. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 148. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 149. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 150. FRANCE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 151. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 152. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 154. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 155. GERMANY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 157. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 158. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 159. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 160. ISRAEL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 164. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 165. ITALY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 167. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 168. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 169. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 170. NETHERLANDS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 171. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 172. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 174. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 175. NIGERIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 177. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 178. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 179. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 180. NORWAY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 184. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 185. POLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 187. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 188. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 189. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 190. QATAR BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 191. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 192. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 193. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 194. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 195. RUSSIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 197. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 198. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 199. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 200. SAUDI ARABIA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 201. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 202. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 203. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 204. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 205. SOUTH AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 206. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 207. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 208. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 209. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 210. SPAIN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 211. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 212. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 213. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 214. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 215. SWEDEN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 216. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 217. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 218. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 219. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 220. SWITZERLAND BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 221. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 222. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 223. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 224. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 225. TURKEY BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 227. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 228. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 229. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 230. UNITED ARAB EMIRATES BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 231. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 232. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 233. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SWABS, 2018-2030 (USD MILLION)
• TABLE 234. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 235. UNITED KINGDOM BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 236. BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 237. BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2023

The Biological Sample Handling Market was valued at USD 18.62 billion in 2023, expected to reach USD 19.85 billion in 2024, and is projected to grow at a CAGR of 6.47%, to USD 28.88 billion by 2030.

The biological sample handling market encompasses a wide range of activities necessary for the effective management, processing, and preservation of biological samples. This process is vital for maintaining the integrity and viability of samples used in diagnostic testing, drug discovery, and biobanking. The necessity of robust sample handling practices arises from the increased demand for precise and reliable results in clinical trials, epidemiological studies, and personalized medicine. Applications of sample handling are broad, spanning clinical laboratories, hospitals, research institutions, and pharmaceutical companies. Key influencing growth factors include the rise in chronic diseases, advancements in biotechnologies, and the expansion of genomic research requiring high-quality sample management. Also noteworthy is the burgeoning interest in precision medicine and personalized healthcare, necessitating enhanced handling procedures. Emerging opportunities exist in automation and innovative technologies like cryopreservation and automated storage systems, which can greatly enhance sample management efficiency. Companies can capitalize on areas such as blockchain for data integrity and AI for predictive sample analytics to gain a competitive edge. However, challenges to market growth include stringent regulatory requirements, high costs associated with advanced handling technologies, and limited awareness in developing regions. Quality control issues also pose a substantial risk to market development. The best areas for innovation involve improving sustainability practices, integrating IoT for real-time monitoring, and enhancing bioinformatics for better data management. Research into novel preservation methods and the development of eco-friendly, cost-effective storage solutions can also foster growth. The market is highly dynamic in nature, with a focus on technological advancements and partnerships among key players to streamline operations and expand reach. Businesses should prioritize continuous innovation and strategic collaborations to mitigate challenges and leverage emerging opportunities effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biological Sample Handling Market

The Biological Sample Handling Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing need for fluid sample management and handling in personalized healthcare
  • Growing demand from genomics and proteomics and the rise in biobanking practices
  • Exponential growth of biomarker analysis and the need for sophisticated sample handling
• Market Restraints
  • Strict regulations associated with biological sample handling
• Market Opportunities
  • Increasing investment in life sciences R&D activities
  • Technological advancements and innovations in sample handling
• Market Challenges
  • Complexity associated with operations and need for specific handling protocols

Porter's Five Forces: A Strategic Tool for Navigating the Biological Sample Handling Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biological Sample Handling Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biological Sample Handling Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biological Sample Handling Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biological Sample Handling Market

A detailed market share analysis in the Biological Sample Handling Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biological Sample Handling Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biological Sample Handling Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biological Sample Handling Market

A strategic analysis of the Biological Sample Handling Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biological Sample Handling Market, highlighting leading vendors and their innovative profiles. These include Accelerated Laboratory Logistics, Alliance Pharma PLC, Azenta Life Sciences, BioDock Limited, BioLife Solutions Inc., Clinigen Group, Cryoniss, Cryoport Systems, LLC, Discovery Life Sciences, Eppendorf SE, Hamilton Company, Infiuss Health, Labtoo, Marken by United Parcel Service, Inc., Mercury Business Services, MLM Medical Labs, Oximio, PrecisionMed, LLC, ReproCELL Inc., SAROUTE Co., Ltd., SPT Labtech Ltd., Thermo Fisher Scientific Inc., and Ziath Ltd..

Market Segmentation & Coverage

This research report categorizes the Biological Sample Handling Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Cellular & Genetic Material, Saliva Samples, Stool Samples, and Urine Samples.
• Based on Product, market is studied across Blood Collection Kits, Swabs, and Viral Transport Media. The Swabs is further studied across Nasal Swabs, Nasopharyngeal Swabs, and Oropharyngeal Swabs.
• Based on End-Use, market is studied across Diagnostic Centers, Homecare, and Hospitals & Clinics.
• Based on Application, market is studied across Diagnostics and Research.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing need for fluid sample management and handling in personalized healthcare
    • 5.1.1.2. Growing demand from genomics and proteomics and the rise in biobanking practices
    • 5.1.1.3. Exponential growth of biomarker analysis and the need for sophisticated sample handling
  • 5.1.2. Restraints
    • 5.1.2.1. Strict regulations associated with biological sample handling
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing investment in life sciences R&D activities
    • 5.1.3.2. Technological advancements and innovations in sample handling
  • 5.1.4. Challenges
    • 5.1.4.1. Complexity associated with operations and need for specific handling protocols
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Growing usage of blood collection kits and swabs for preserving viral samples during transportation
  • 5.2.2. End-Use: Increasing adoption of biological sample handling solutions in hospitals promoting proactive health management
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biological Sample Handling Market, by Type

• 6.1. Introduction
• 6.2. Cellular & Genetic Material
• 6.3. Saliva Samples
• 6.4. Stool Samples
• 6.5. Urine Samples

7. Biological Sample Handling Market, by Product

• 7.1. Introduction
• 7.2. Blood Collection Kits
• 7.3. Swabs
  • 7.3.1. Nasal Swabs
  • 7.3.2. Nasopharyngeal Swabs
  • 7.3.3. Oropharyngeal Swabs
• 7.4. Viral Transport Media

8. Biological Sample Handling Market, by End-Use

• 8.1. Introduction
• 8.2. Diagnostic Centers
• 8.3. Homecare
• 8.4. Hospitals & Clinics

9. Biological Sample Handling Market, by Application

• 9.1. Introduction
• 9.2. Diagnostics
• 9.3. Research

10. Americas Biological Sample Handling Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Biological Sample Handling Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Biological Sample Handling Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
  • 13.3.1. MedLife to Transport Lab Samples with Drones
  • 13.3.2. BioLizard and Parean Biotechnologies Announce Partnership
  • 13.3.3. MolGen Acquires Synchron Lab Automation
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Accelerated Laboratory Logistics
• 2. Alliance Pharma PLC
• 3. Azenta Life Sciences
• 4. BioDock Limited
• 5. BioLife Solutions Inc.
• 6. Clinigen Group
• 7. Cryoniss
• 8. Cryoport Systems, LLC
• 9. Discovery Life Sciences
• 10. Eppendorf SE
• 11. Hamilton Company
• 12. Infiuss Health
• 13. Labtoo
• 14. Marken by United Parcel Service, Inc.
• 15. Mercury Business Services
• 16. MLM Medical Labs
• 17. Oximio
• 18. PrecisionMed, LLC
• 19. ReproCELL Inc.
• 20. SAROUTE Co., Ltd.
• 21. SPT Labtech Ltd.
• 22. Thermo Fisher Scientific Inc.
• 23. Ziath Ltd.